Sofinnova Investments’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$29.3M	Buy	548,788 +38,768	+8%	+$2.07M	1.79%	18
2025 Q1	$20.6M	Buy	+510,020	New	+$20.6M	1.35%	24
2020 Q2	–	Sell	-148,415	Closed	-$3.15M	–	67
2020 Q1	$3.15M	Buy	+148,415	New	+$3.15M	0.29%	40